BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 12075357)

  • 1. Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth.
    Urano T; Saito T; Tsukui T; Fujita M; Hosoi T; Muramatsu M; Ouchi Y; Inoue S
    Nature; 2002 Jun; 417(6891):871-5. PubMed ID: 12075357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic and proteolytic inactivation of 14-3-3sigma in breast and prostate cancers.
    Horie-Inoue K; Inoue S
    Semin Cancer Biol; 2006 Jun; 16(3):235-9. PubMed ID: 16682214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen-responsive RING finger protein controls breast cancer growth.
    Horie K; Urano T; Ikeda K; Inoue S
    J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):101-4. PubMed ID: 12943693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen-responsive finger protein as a new potential biomarker for breast cancer.
    Suzuki T; Urano T; Tsukui T; Horie-Inoue K; Moriya T; Ishida T; Muramatsu M; Ouchi Y; Sasano H; Inoue S
    Clin Cancer Res; 2005 Sep; 11(17):6148-54. PubMed ID: 16144914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing 14-3-3 sigma expression with declining estrogen receptor alpha and estrogen-responsive finger protein expression defines malignant progression of endometrial carcinoma.
    Nakayama H; Sano T; Motegi A; Oyama T; Nakajima T
    Pathol Int; 2005 Nov; 55(11):707-15. PubMed ID: 16271083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of Efp by DNA-modified small interfering RNA inhibits breast cancer cell proliferation and in vivo tumor growth.
    Ueyama K; Ikeda K; Sato W; Nakasato N; Horie-Inoue K; Takeda S; Inoue S
    Cancer Gene Ther; 2010 Sep; 17(9):624-32. PubMed ID: 20467453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oestrogen causes degradation of KLF5 by inducing the E3 ubiquitin ligase EFP in ER-positive breast cancer cells.
    Zhao KW; Sikriwal D; Dong X; Guo P; Sun X; Dong JT
    Biochem J; 2011 Jul; 437(2):323-33. PubMed ID: 21542805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oestrogen causes ATBF1 protein degradation through the oestrogen-responsive E3 ubiquitin ligase EFP.
    Dong XY; Fu X; Fan S; Guo P; Su D; Dong JT
    Biochem J; 2012 Jun; 444(3):581-90. PubMed ID: 22452784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIAH-1 interacts with alpha-tubulin and degrades the kinesin Kid by the proteasome pathway during mitosis.
    Germani A; Bruzzoni-Giovanelli H; Fellous A; Gisselbrecht S; Varin-Blank N; Calvo F
    Oncogene; 2000 Dec; 19(52):5997-6006. PubMed ID: 11146551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efp as a primary estrogen-responsive gene in human breast cancer.
    Ikeda K; Orimo A; Higashi Y; Muramatsu M; Inoue S
    FEBS Lett; 2000 Apr; 472(1):9-13. PubMed ID: 10781795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efp promotes in vitro and in vivo growth of endometrial cancer cells along with the activation of nuclear factor-κB signaling.
    Sato W; Ikeda K; Urano T; Abe Y; Nakasato N; Horie-Inoue K; Takeda S; Inoue S
    PLoS One; 2018; 13(12):e0208351. PubMed ID: 30586414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cloning of rat efp: expression and regulation in primary osteoblasts.
    Inoue S; Urano T; Ogawa S; Saito T; Orimo A; Hosoi T; Ouchi Y; Muramatsu M
    Biochem Biophys Res Commun; 1999 Aug; 261(2):412-8. PubMed ID: 10425199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptors and their downstream targets in cancer.
    Ikeda K; Inoue S
    Arch Histol Cytol; 2004 Dec; 67(5):435-42. PubMed ID: 15781984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Src promotes estrogen-dependent estrogen receptor alpha proteolysis in human breast cancer.
    Chu I; Arnaout A; Loiseau S; Sun J; Seth A; McMahon C; Chun K; Hennessy B; Mills GB; Nawaz Z; Slingerland JM
    J Clin Invest; 2007 Aug; 117(8):2205-15. PubMed ID: 17627304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression.
    Laronga C; Yang HY; Neal C; Lee MH
    J Biol Chem; 2000 Jul; 275(30):23106-12. PubMed ID: 10767298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the p53-MDM2 pathway by 14-3-3 sigma and other proteins.
    Lee MH; Lozano G
    Semin Cancer Biol; 2006 Jun; 16(3):225-34. PubMed ID: 16697215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein.
    Tanimoto K; Makino Y; Pereira T; Poellinger L
    EMBO J; 2000 Aug; 19(16):4298-309. PubMed ID: 10944113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association with cullin partners protects ROC proteins from proteasome-dependent degradation.
    Ohta T; Michel JJ; Xiong Y
    Oncogene; 1999 Nov; 18(48):6758-66. PubMed ID: 10597284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome mapping of human (ZNF147) and mouse genes for estrogen-responsive finger protein (efp), a member of the RING finger family.
    Inoue S; Orimo A; Matsuda Y; Inazawa J; Emi M; Nakamura Y; Hori T; Muramatsu M
    Genomics; 1995 Jan; 25(2):581-3. PubMed ID: 7789997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of estrogen-responsive finger protein expression in benign and malignant human breast.
    Thomson SD; Ali S; Pickles L; Taylor J; Pace PE; Lymboura M; Shousha S; Coombes RC
    Int J Cancer; 2001 Jan; 91(2):152-8. PubMed ID: 11146438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.